Tylenol with Naproxen: FDA Approves New 12-Hour Pain Relief Tablet

FDA approves Tylenol with Naproxen, the first OTC pain reliever combining acetaminophen and naproxen for 12-hour relief

American consumers are about to get a genuinely new option in the crowded world of over-the-counter pain relief. On July 24, 2026, the U.S. Food and Drug Administration approved Tylenol with Naproxen, a fixed-dose, non-prescription tablet that combines 650 mg of acetaminophen with 220 mg of naproxen sodium. It is the first and only over-the-counter product of its kind, and it marks one of the more significant developments in non-opioid pain medication in years.
For decades, people managing headaches, back pain, muscle aches, toothaches, menstrual cramps, and minor arthritis pain have had to choose between two well-known but separate medicines acetaminophen (Tylenol) or naproxen sodium (Aleve) or combine them on their own, without official guidance on dosing or timing. That changes with the arrival of Tylenol with Naproxen, which brings both ingredients together in a single tablet designed to start working quickly and keep working for up to 12 hours.

This article breaks down what Tylenol with Naproxen is, how it works, what the clinical research shows, how it compares to other over-the-counter pain medication, and what it means for the roughly 75% of persistent pain sufferers who say they're dissatisfied with their current relief options.

What Is Tylenol with Naproxen?

Tylenol with Naproxen is the first FDA approved, over the counter fixed dose combination of acetaminophen and naproxen sodium. Each tablet contains 650 mg of acetaminophen the active ingredient found in original Tylenol and 220 mg of naproxen sodium, the same active ingredient found in Aleve. Until this approval, these two acetaminophen and naproxen combination ingredients had never been packaged together as a single, FDA-sanctioned non-prescription tablet.

The product is approved for use by adults and children aged 12 and older, and it is indicated for the temporary relief of minor aches and pains, including:

• Headache

• Back pain

• Muscle aches

• Toothaches

• Menstrual cramps

• Minor pain associated with arthritis 

Because it is a non-opioid pain medication, Tylenol with Naproxen carries none of the addiction risk associated with prescription opioid painkillers, while still offering meaningfully stronger and longer-lasting relief than either ingredient alone. According to the U.S. Department of Labor, up to one in four patients prescribed opioids are at risk of developing dependence a statistic that underscores why an effective, easily accessible, non-opioid option matters so much to public health.

FDA Approves Tylenol with Naproxen: What the Agency Said

The news that the FDA approves Tylenol with Naproxen comes at a moment when regulators have been actively looking for ways to expand safe, effective over-the-counter pain relief options. In its announcement, the FDA noted that this approval aligns with a broader healthcare initiative aimed at making more prescription-strength-equivalent treatments available without a prescription, so that consumers have easier access to medications that have already demonstrated strong safety and efficacy profiles.

The approval also comes with a notable business detail: the FDA has granted Kenvue, the company that owns Tylenol, a three-year period of marketing exclusivity for this specific formulation. That means no other manufacturer will be permitted to sell an identical over-the-counter fixed-dose combination of acetaminophen and naproxen sodium during that window, giving Kenvue a head start in a category it says has been underserved for years.

Kenvue has confirmed that Tylenol with Naproxen will soon be available for purchase without a prescription at major retailers nationwide, following the standard rollout timeline for new over-the-counter drug products.

How Tylenol with Naproxen Works

One of the more interesting aspects of Tylenol with Naproxen is that it doesn't rely on a single mechanism of action. Instead, it pairs two different types of pain relievers that work in complementary ways.
Acetaminophen is believed to act primarily in the central nervous system, helping to quickly reduce the perception of pain signals. It has long been valued for its fast onset and its relatively gentle profile on the stomach compared with anti-inflammatory drugs.
Naproxen sodium, on the other hand, is a non-steroidal anti-inflammatory drug (NSAID). Rather than simply dulling pain signals, it works by reducing the inflammation that is often the underlying source of pain which is part of why naproxen sodium tablets have long been a go-to choice for muscle pain medication, joint discomfort, and arthritis-related aches.
According to Michelle Bateson, who oversees North America research and development at Kenvue, the two ingredients "work differently" acetaminophen offers quick relief from pain signals while naproxen sodium addresses pain tied to inflammation. Combining them in one tablet allows Tylenol with Naproxen to deliver both a fast onset of action and a longer duration of relief than either ingredient could provide on its own.

In practical terms, Kenvue says Tylenol with Naproxen begins working in under 30 minutes and continues providing relief for a full 12 hours from a single dose a combination of speed and duration that neither standalone acetaminophen pain reliever nor standalone naproxen sodium products have been able to match in a single tablet.

The Clinical Evidence Behind Tylenol with Naproxen

Regulatory approval for a new over-the-counter pain relief product doesn't happen without a substantial body of clinical evidence, and Tylenol with Naproxen is no exception. Kenvue says the combination was evaluated across eight separate clinical studies before receiving the FDA's green light.

Across those studies, Tylenol with Naproxen demonstrated:

• Superior pain relief compared to acetaminophen alone

• Superior pain relief compared to naproxen sodium alone (specifically benchmarked against Aleve 220 mg)

• Onset of relief in under 30 minutes

• Sustained pain relief for 12 hours following a single dose

Dr. Todd Bertoch, Chief Medical Officer of Pain Research at CenExel Clinical Research and a principal investigator on the clinical program, explained that the research was designed to answer a very practical question: could a fixed-dose, opioid-free over-the-counter option deliver both fast onset and sustained pain relief, without requiring patients to combine multiple products on their own? Based on the results, he said the 650 mg acetaminophen and 220 mg naproxen sodium fixed-dose combination "consistently outperformed either ingredient alone" throughout the clinical program.

Additional clinical data on Tylenol with Naproxen, drawn from multiple pain models used in the studies, is expected to be presented at upcoming medical conferences, including PAINWeek 2026 giving physicians and pharmacists further opportunity to evaluate the evidence firsthand.

Why This Matters: A Gap in Persistent Pain Relief

Perhaps the most striking data point behind this launch isn't clinical it's about consumer experience. According to a Kenvue Pain Consumer Survey conducted in March 2026, which included more than 6,200 respondents, roughly 75% of persistent pain sufferers reported dissatisfaction with their current pain relief options.

That statistic highlights a real gap in the market. Many people dealing with ongoing pain whether from arthritis, chronic back pain, or recurring headaches have historically faced a difficult choice: rely on a single OTC pain reliever that may not be strong enough, attempt to combine two different medications on their own without formal guidance, or turn to a prescription option, which may involve opioids and their associated risks.

Tylenol with Naproxen is designed to close that gap. By offering a clinically studied, pre-formulated combination in one tablet, it removes the guesswork of staggering doses of two separate medications while still avoiding the risks tied to opioid pain relievers. For many consumers, this kind of simplified regimen could mean better adherence to their pain management plan and, ultimately, better outcomes.

Tylenol with Naproxen Benefits at a Glance

To summarize why this approval is generating so much attention, here are the core Tylenol with Naproxen benefits highlighted by Kenvue and the clinical research supporting the product:

• Fast onset: Begins working in under 30 minutes.

• Long duration: Provides pain relief for up to 12 hours from a single dose.

• Dual mechanism: Combines the pain-signal-blocking action of acetaminophen with the anti-inflammatory action of naproxen sodium.

• Non-opioid pain medication: Carries no risk of opioid-related dependence.

• Clinically validated: Backed by eight clinical studies showing superior performance compared to either ingredient alone.

• Convenient dosing: Eliminates the need to time or coordinate two separate over-the-counter medications.

• Broad indication: Approved for headaches, back pain, muscle aches, toothaches, menstrual cramps, and minor arthritis pain.

• Wide accessibility: Available without a prescription, unlike many stronger combination pain therapies.

How Tylenol with Naproxen Compares to Other OTC Pain Relievers

When people search for the best OTC pain medicine, they're usually choosing among a handful of familiar names: standard Tylenol, ibuprofen products, and Aleve. Here's how Tylenol with Naproxen fits into that landscape.
Standard Tylenol (acetaminophen only): Acts quickly on pain signals and is generally well tolerated, but on its own it doesn't specifically target inflammation, which can limit its effectiveness for conditions like arthritis or muscle inflammation.
Aleve (naproxen sodium only): As an NSAID, it's effective against inflammatory pain and offers a longer duration than many other options, but it may take longer to bring noticeable relief compared with acetaminophen.
Tylenol with Naproxen (the combination): By pairing the two, it aims to deliver the best of both the fast action associated with acetaminophen and the sustained, anti-inflammatory relief associated with naproxen sodium in one dose, one tablet, and one simplified regimen.
This is part of why Kenvue is positioning Tylenol with Naproxen not simply as another headache pain relief tablet, but as a broader solution for people managing multiple types of everyday and persistent pain.

Backed by Decades of Tylenol Innovation

Kenvue is emphasizing that this launch builds on more than 70 years of experience in acetaminophen research, safety monitoring, and product development under the Tylenol brand. The company points to a track record of category-defining firsts, including the introduction of the first children's liquid acetaminophen product and the establishment of higher-dose formulations, such as 500 mg Extra Strength Tylenol, as new standards in over-the-counter pain relief.
Dr. Rajesh Mishra, Chief Medical Officer at Kenvue, said the approval "reflects the long-standing leadership of Tylenol in translating rigorous clinical science into accessible, over-the-counter solutions." He noted that persistent pain often leaves people cycling through trial and error, choosing between short-term relief and more complex treatment approaches and that Tylenol with Naproxen is meant to simplify that decision by combining fast onset, 12-hour duration, and the established safety profiles of two well-known non-opioid ingredients into a single fixed dose.

Addressing the Broader Context: Tylenol and Public Scrutiny

It's worth noting that this approval arrives against a backdrop of public debate involving Tylenol. In 2025, there was public discussion, including comments from federal officials, questioning a possible link between acetaminophen use during pregnancy and autism in children a claim that has not been supported by the medical and scientific consensus. Major medical organizations and doctors have continued to state that acetaminophen remains the preferred option for treating pain and fever during pregnancy when used as directed, and Kenvue has consistently maintained that Tylenol is safe when used according to label instructions.

Separately, the state of Texas filed a lawsuit against Kenvue in 2025 alleging the company failed to adequately warn consumers about potential risks associated with the drug during pregnancy, and a U.S. appeals court has since revived several hundred related private lawsuits raising similar claims. These legal matters remain distinct from the FDA's evaluation and approval process for Tylenol with Naproxen, which was based on the eight clinical studies specifically conducted for this new fixed-dose combination product.

Consumers considering Tylenol with Naproxen, like any over-the-counter medication, should read and follow the Drug Facts label carefully and consult a healthcare professional if they have questions about whether the product is appropriate for their individual health circumstances, including during pregnancy or while managing other medical conditions.

Who Should Use Tylenol with Naproxen and Who Should Check With a Doctor First

Tylenol with Naproxen is approved for adults and children aged 12 and older seeking temporary relief from common types of pain. That said, because the product combines an NSAID with acetaminophen, it's especially important for consumers to review the Drug Facts label before use, particularly if they:

• Have a history of stomach ulcers or gastrointestinal bleeding

• Have kidney or liver conditions

• Are taking other medications that contain acetaminophen or NSAIDs

• Are pregnant or breastfeeding

• Have cardiovascular risk factors, as is standard guidance for NSAID-containing products

As with any FDA-approved pain medication, the label will include specific dosing instructions, maximum daily limits, and warnings designed to help consumers use the product safely. Kenvue and the FDA both emphasize that consulting a healthcare professional is the best way to determine whether Tylenol with Naproxen is the right choice for a particular individual's needs.

When and Where to Buy Tylenol with Naproxen

Tylenol with Naproxen is expected to arrive at major U.S. retailers nationwide in the coming months, following typical timelines for rolling out a newly approved over-the-counter product. Because Kenvue holds a three-year period of exclusivity on this exact fixed-dose formulation, it will be the only company legally permitted to sell this specific acetaminophen-and-naproxen-sodium combination during that period.

Consumers interested in learning more about availability, dosing, and safety information can visit Kenvue's official Tylenol website, or find broader company information including investor filings and corporate updates at Kenvue's corporate site.

The Bigger Picture: A New Category-Defining OTC Painkiller

The approval of Tylenol with Naproxen represents more than just a single new product launch it reflects a broader shift in how regulators and manufacturers are approaching pain management in the United States. As concerns about opioid dependence continue to shape healthcare policy, there's clear demand for non-opioid pain medication options that can deliver meaningful, reliable relief without the risks associated with stronger prescription drugs.

By combining two of the most trusted names in over-the-counter pain relief acetaminophen and naproxen sodium into a single, clinically validated tablet, Kenvue has positioned Tylenol with Naproxen as a genuinely new over-the-counter painkiller category, rather than simply another line extension of an existing product. The fact that the FDA granted a three-year exclusivity period underscores how novel this fixed-dose combination is within the regulatory landscape.

For consumers who have grown frustrated trying to manage headaches, back pain, muscle pain, toothaches, menstrual cramps, or arthritis discomfort with existing options, Tylenol with Naproxen offers a streamlined alternative one tablet, taken as directed, aiming to deliver fast relief that lasts through the day or night.

Final Thoughts

The FDA's approval of Tylenol with Naproxen marks a meaningful moment in the evolution of over-the-counter pain relief. As the first and only non-prescription fixed-dose combination of acetaminophen and naproxen sodium, it offers a fast-acting, long-lasting, non-opioid option backed by eight clinical studies and more than 70 years of Tylenol's history in pain management innovation.

With Tylenol with Naproxen set to hit major retail shelves soon, consumers dealing with everyday and persistent pain will have a new tool to consider one designed to simplify their routine while addressing a gap that, according to Kenvue's own research, affects roughly three out of every four people managing ongoing pain. As always, anyone considering Tylenol with Naproxen should read the label carefully and talk with a healthcare provider about whether it's the right fit for their specific needs.

FAQ

What This Means for the Future of OTC Pain Relief

The approval of Tylenol with Naproxen could also signal what's ahead for the broader over-the-counter pain relief category. As regulators continue to look for ways to responsibly expand access to effective, non-opioid pain medication, fixed-dose combination products like this one may become more common, provided they're supported by the same level of clinical rigor Kenvue applied here.

For now, Tylenol with Naproxen stands alone as the first and only product of its kind a milestone that reflects both a scientific achievement and a direct response to what consumers have been asking for. Whether it's used for a stubborn headache, a sore back after a long week, or the recurring discomfort of minor arthritis, Tylenol with Naproxen gives consumers a new, clinically backed, non-opioid tool to add to their pain management routine.

Note: This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new medication, including Tylenol with Naproxen. Images are generated for clear visuals.